Changes in psychotropic polypharmacy and high‐potency prescription following policy change: Findings from a large scale Japanese claims database

Author:

Takeshima Masahiro1ORCID,Enomoto Minori2,Ogasawara Masaya1,Kudo Mizuki1,Itoh Yu1,Yoshizawa Kazuhisa1,Fujiwara Dai1,Takaesu Yoshikazu3ORCID,Mishima Kazuo1ORCID

Affiliation:

1. Department of Neuropsychiatry Akita University Graduate School of Medicine Akita Japan

2. Department of Medical Technology, School of Health Sciences Tokyo University of Technology Tokyo Japan

3. Department of Neuropsychiatry, Graduate School of Medicine University of the Ryukyus Okinawa Japan

Publisher

Wiley

Subject

Psychiatry and Mental health,Neurology (clinical),Neurology,General Medicine,General Neuroscience

Reference10 articles.

1. Ministry of Health Labour and Welfare.Medical fee revision (in Japanese). [Cited 27 January 2022.] Available fromhttps://www.mhlw.go.jp/stf/seisakunitsuite/bunya/0000106602.html

2. Japan Psychiatric Rating Scales Association.Psychotropic dose equivalence in Japan.2017. [Cited 27 January 2022.] Available fromhttp://jsprs.org/toukakansan/2017ver/

3. Long-term Diazepam Therapy and Clinical Outcome

4. Does cognitive behavioral therapy for anxiety disorders assist the discontinuation of benzodiazepines among patients with anxiety disorders? A systematic review and meta‐analysis

5. Psychosocial intervention for discontinuing benzodiazepine hypnotics in patients with chronic insomnia: A systematic review and meta-analysis

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3